NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,199 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,199 Papers indexed
1,440 Papers AI scored
40,199 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-07 10:15 AM
1 Social Determinants of Sleep Health in Survivors of Childhood Cancer: A Systematic Review. Journal of sleep research — Nov 07, 2026 2 Primitive neuroectodermal tumour of the left posterior mandible. BMJ case reports — Nov 07, 2026 3 Adrenal ganglioneuroma in an adolescent presenting as an incidentaloma: Imaging-pathology correlation and diagnostic challenges: A case report. Medicine — Nov 07, 2026 4 Synchronous hepatocellular carcinoma and nasopharyngeal carcinoma in a patient with chronic hepatitis B: A case report and literature review. Medicine — Nov 07, 2026 5 Prenatal Trio Exome Sequencing in Low-Risk Pregnancies: Diagnostic Yield and Clinical Implications. Clinical genetics — Nov 07, 2026 6 Defining and validating an HPV vaccination motivation score in Kenya and Malawi: A tool for use in low- and middle-income countries. Vaccine — Nov 07, 2026 7 Drawing the Sacred: Visualizing Where Hope Lives in Hispanic Adolescent and Young Adult Cancer Survivorship. Journal of adolescent and young adult oncology — Nov 07, 2026 8 Social Isolation in Japanese Adolescents and Young Adults with Hematologic Malignancies: A Focus on Peer Relationships and Occupational Therapy Implications. Journal of adolescent and young adult oncology — Nov 07, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40199 results
C
A case-based review of adult-onset craniopharyngioma.
PMID 40444237 Published: 2025-05-15 Ingested: 2026-08-02 12:03 AM Frontiers in endocrinology
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
[One case of eustachian tube hairy polyp was removed by microscope combined with endoscope].
PMID 40443384 Published: 2025-06-01 Ingested: 2026-08-02 12:04 AM Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Pediatric Cancer Genetics and Genomics.
PMID 40435402 Published: 2025-05-28 Ingested: 2026-08-02 12:04 AM Annual review of genomics and human genetics
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Rhabdomyosarcoma Classification: Refining Our Understanding.
PMID 40412828 Published: 2024-12-10 Ingested: 2026-08-02 12:03 AM Surgical pathology clinics
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Rare Primary ALK-Positive Anaplastic Large Cell Lymphoma of the Central Nervous System.
PMID 40403291 Published: 2025-05-12 Ingested: 2026-08-02 12:04 AM Oncology (Williston Park, N.Y.)
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
A 7-Year-Old Girl With Multiple Pulmonary Nodules.
PMID 40348519 Published: 2025-05-01 Ingested: 2026-08-02 12:04 AM Chest
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Langerhans Cell Histiocytosis of Bone:Report of Eight Cases and Review of the Literature.
PMID 40331395 Published: 2025-04-30 Ingested: 2026-08-02 12:04 AM Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Unusual Bone Metastasis Neuroblastoma in Adolescent With Unidentified Primary Site.
PMID 40330257 Published: 2025-05-06 Ingested: 2026-08-02 12:04 AM Clinical case reports
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
A Comparative Analysis of the Protection of the Rights of Childhood Cancer Survivors to Education Under Special Education Law.
PMID 40321897 Published: 2025-04-30 Ingested: 2026-08-02 12:03 AM Continuity in education
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Inflammatory Myofibroblastic Tumor: An Updated Review.
PMID 40282503 Published: 2025-04-15 Ingested: 2026-08-02 12:04 AM Cancers
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Universal Premedication Does Not Impact Transition to Short-acting Asparaginase or Incidence of Hypersensitivity to Pegylated Asparaginase: A Single-institution Experience.
PMID 40231803 Published: 2025-04-10 Ingested: 2026-08-02 12:04 AM Journal of pediatric hematology/oncology
AI -
Standard 55.4
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 55.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Previous
Page 2587 of 3350
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic